eHealth - EHTH Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for eHealth in the last twelve months. There are currently 7 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" EHTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EHTH, but not buy additional shares or sell existing shares.
View EHTH analyst ratings or view top-rated stocks.

7 Wall Street analysts have issued 1-year price targets for eHealth's shares. Their EHTH share price forecasts range from $8.00 to $22.00. On average, they predict the company's stock price to reach $12.31 in the next twelve months. This suggests a possible upside of 214.9% from the stock's current price.
View analysts price targets for EHTH or view top-rated stocks among Wall Street analysts.

eHealth's stock was trading at $25.50 on January 1st, 2022. Since then, EHTH shares have decreased by 84.7% and is now trading at $3.91.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our EHTH earnings forecast.

eHealth, Inc. (NASDAQ:EHTH) announced its earnings results on Monday, August, 8th. The financial services provider reported ($1.33) earnings per share for the quarter, topping analysts' consensus estimates of ($1.41) by $0.08. The financial services provider earned $50.40 million during the quarter, compared to analyst estimates of $74.89 million. eHealth had a negative trailing twelve-month return on equity of 15.24% and a negative net margin of 33.56%. The firm's revenue for the quarter was down 47.8% on a year-over-year basis. During the same period in the previous year, the business posted ($0.70) EPS.

eHealth updated its FY 2022 earnings guidance on Tuesday, September, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $375.00 million-$395.00 million, compared to the consensus revenue estimate of $459.73 million.

60 employees have rated eHealth Chief Executive Officer Scott Flanders on Glassdoor.com. Scott Flanders has an approval rating of 67% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other eHealth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Advanced Micro Devices (AMD), AbbVie (ABBV), Tesla (TSLA), Netflix (NFLX), Salesforce (CRM), DocuSign (DOCU) and JPMorgan Chase & Co. (JPM).

eHealth trades on the NASDAQ under the ticker symbol "EHTH."

Shares of EHTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EHTH stock can currently be purchased for approximately $3.91.

eHealth (NASDAQ:EHTH) has a market capitalization of $106.59 million and generates $538.20 million in revenue each year. The financial services provider earns $-104,380,000.00 in net income (profit) each year or ($6.80) on an earnings per share basis.

The company employs 2,379 workers across the globe.

eHealth's mailing address is 2625 AUGUSTINE DRIVE SECOND FLOOR, SANTA CLARA CA, 95054. The official website for the company is www.ehealthinsurance.com. The financial services provider can be reached via phone at (877) 456-7180, via email at kate.sidorovich@ehealth.com, or via fax at 650-961-2153.